Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
There is a strong link between fecal microbiota and the development of type 1 diabetes. As an emerging therapeutic modality, fecal microbiota transplantation has been shown to be safe and effective in the treatment of many intestinal and extraintestinal diseases. Various studies have found that feca...
Main Authors: | Shuo Zhang, Feiying Deng, Jingxian Chen, Fengwu Chen, Zezhen Wu, Liping Li, Kaijian Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1075201/full |
Similar Items
-
Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study
by: Zezhen Wu, et al.
Published: (2023-01-01) -
Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
by: Kaijian Hou, et al.
Published: (2022-06-01) -
Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
by: Yu Su, et al.
Published: (2023-01-01) -
Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
by: Shuo Zhang, et al.
Published: (2023-05-01) -
Relationship between gut microbiota and the pathogenesis of gestational diabetes mellitus: a systematic review
by: Sheng Ma, et al.
Published: (2024-05-01)